STAT+: ‘A step in the right direction for national security’: An antibiotic plant reopens in Tennessee to make penicillin
Amid a push to bolster antibiotic manufacturing in the U.S., a facility that closed last year due to bankruptcy has been reopened by new ownership, which hopes to jump-start production and meet nationwide demand for a widely prescribed treatment.
Jackson Healthcare expects the USAntibiotics plant in Bristol, Tenn., to produce 300 million capsules and 2 billion tablets of amoxicillin and its variants annually, and stockpile a five-year supply for the U.S. Amoxicillin, a member of the penicillin family, makes up about one-third of all antibiotics prescribed in the U.S. each year.